Cargando…

A noninferiority design for a delayed calcineurin inhibitor substitution trial in kidney transplantation

Improving long‐term kidney transplant outcomes requires novel treatment strategies, including delayed calcineurin inhibitor (CNI) substitution, tested using informative trial designs. An alternative approach to the usual superiority‐based trial is a noninferiority trial design that tests whether an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nickerson, Peter W., Balshaw, Robert, Wiebe, Chris, Ho, Julie, Gibson, Ian W., Bridges, Nancy D., Rush, David N., Heeger, Peter S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	ORIGINAL ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8048676/ https://www.ncbi.nlm.nih.gov/pubmed/32956576 http://dx.doi.org/10.1111/ajt.16311

Ejemplares similares

The negative impact of T cell–mediated rejection on renal allograft survival in the modern era
por: Rampersad, Christie, et al.
Publicado: (2021)

Multicentre randomised controlled trial protocol of urine CXCL10 monitoring strategy in kidney transplant recipients
por: Ho, Julie, et al.
Publicado: (2019)

Hyperacute Antibody-mediated Rejection Associated With Red Blood Cell Antibodies
por: Shaw, James, et al.
Publicado: (2019)

Detecting Renal Allograft Inflammation Using Quantitative Urine Metabolomics and CXCL10
por: Ho, Julie, et al.
Publicado: (2016)

Pathology of Calcineurin and Mammalian Target of Rapamycin Inhibitors in Kidney Transplantation
por: Leal, Rita, et al.
Publicado: (2017)

The effect of calcineurin inhibitors on anthropometric measurements in kidney transplant recipients
por: Sayilar, Emel Isiktas, et al.
Publicado: (2022)

Basiliximab Induction with Delayed Calcineurin Inhibitors for High-Risk Lung Transplant Candidates
por: Kim, Ha Eun, et al.
Publicado: (2021)

HLA‐DR/DQ molecular mismatch: A prognostic biomarker for primary alloimmunity
por: Wiebe, Chris, et al.
Publicado: (2018)

Defining the noninferiority margin and analysing noninferiority: An overview
por: Althunian, Turki A., et al.
Publicado: (2017)

Evidence for the alloimmune basis and prognostic significance of Borderline T cell–mediated rejection
por: Wiebe, Chris, et al.
Publicado: (2020)

Pharmacokinetic and Pharmacodynamic Considerations in Relation to Calcineurin Usage in Elderly Kidney Transplant Recipients
por: Cossart, Amelia R., et al.
Publicado: (2021)

Early calcineurin-inhibitor to belatacept conversion in steroid-free kidney transplant recipients
por: Tawhari, Ibrahim, et al.
Publicado: (2022)

Noninferiority trials
por: Snapinn, Steven M
Publicado: (2000)

Pain syndrome with stress fractures in transplanted patients treated with calcineurin inhibitors
por: Gurin, Lindsey, et al.
Publicado: (2012)

Association of pre-transplant statin use with delayed graft function in kidney transplant recipients
por: Reiling, Janske, et al.
Publicado: (2012)

Interpreting the results of noninferiority trials—a review
por: Cuzick, Jack, et al.
Publicado: (2022)

Calcineurin regulation of cytoskeleton organization: a new paradigm to analyse the effects of calcineurin inhibitors on the kidney
por: Descazeaud, Virginie, et al.
Publicado: (2012)

Understanding noninferiority trials
por: Hahn, Seokyung
Publicado: (2012)

Calcineurin inhibitor-induced pain syndrome after kidney transplantation—a rare but disabling condition
por: Breitenstein, Alexander, et al.
Publicado: (2011)

Proteomic Characterization of Urinary Extracellular Vesicles from Kidney-Transplanted Patients Treated with Calcineurin Inhibitors
por: Carreras-Planella, Laura, et al.
Publicado: (2020)

Association of high intra-patient variability in tacrolimus exposure with calcineurin inhibitor nephrotoxicity in kidney transplantation
por: Kim, Hyokee, et al.
Publicado: (2023)

Calcineurin-Inhibitor Minimization in Liver Transplant Patients with Calcineurin-Inhibitor-Related Renal Dysfunction: A Meta-Analysis
por: Kong, Yuan, et al.
Publicado: (2011)

Calcineurin inhibitor toxicity in a renal transplant recipient
por: Charney, Douglas A., et al.
Publicado: (2009)

Calcineurin
por: Creamer, Trevor P.
Publicado: (2020)

Safety and immunologic benefits of conversion to sirolimus in kidney transplant recipients with long-term exposure to calcineurin inhibitors
por: Yu, Ji Hyun, et al.
Publicado: (2016)

The Privilege of Induction Avoidance and Calcineurin Inhibitors Withdrawal in 2 Haplotype HLA Matched White Kidney Transplantation
por: Brifkani, Zaid, et al.
Publicado: (2017)

Effect of conversion from calcineurin inhibitors to everolimus on hepatitis C viremia in adult kidney transplant recipients
por: Pacheco, Larissa Sgaria, et al.
Publicado: (2018)

Effect of Calcineurin Inhibitors and Mammalian Target of Rapamycin Inhibitors on the Course of COVID-19 in Kidney Transplant Recipients
por: Hasbal, Nuri Baris, et al.
Publicado: (2021)

An Integrated Transcriptomic Approach to Identify Molecular Markers of Calcineurin Inhibitor Nephrotoxicity in Pediatric Kidney Transplant Recipients
por: Rhone, Erika T., et al.
Publicado: (2021)

Potential interactions between uraemic toxins and drugs: an application in kidney transplant recipients treated with calcineurin inhibitors
por: André, Camille, et al.
Publicado: (2021)

Noninferiority Testing in Clinical Trials
por: Ng, Tie-Hua
Publicado: (2014)

Cardiovascular Risk Following Conversion to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: A Randomized Clinical Trial
por: Bredewold, Obbo W., et al.
Publicado: (2022)

Everolimus Based Immunosuppression Strategies in Adult Lung Transplant Recipients: Calcineurin Inhibitor Minimization Versus Calcineurin Inhibitor Elimination
por: Ivulich, Steven, et al.
Publicado: (2023)

Microvascular inflammation is a risk factor in kidney transplant recipients with very late conversion from calcineurin inhibitor-based regimens to belatacept
por: Choi, Mira, et al.
Publicado: (2020)

Rivaroxaban was found to be noninferior to warfarin in routine clinical care: A retrospective noninferiority cohort replication study
por: Althunian, Turki A., et al.
Publicado: (2020)

Noninferiority Margin Size and Acceptance of Trial Results: Contingent Valuation Survey of Clinician Preferences for Noninferior Mortality
por: Pong, Sandra, et al.
Publicado: (2022)

An Unusual Manifestation of Calcineurin Inhibitor-Induced Pain Syndrome in Kidney Transplantation: A Case Report and Literature Review
por: Udomkarnjananun, Suwasin, et al.
Publicado: (2018)

Polymorphisms in mTOR and Calcineurin Signaling Pathways Are Associated With Long-Term Clinical Outcomes in Kidney Transplant Recipients
por: Campos-Salazar, Antony Brayan, et al.
Publicado: (2018)

Belatacept As an Alternative to Calcineurin Inhibitors in Patients with Solid Organ Transplants
por: Kumar, Dhiren, et al.
Publicado: (2017)

Non-Immunologic Actions of Calcineurin Inhibitors in Proteinuric Kidney Diseases
por: Spurney, Robert Frank
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_8hs1ebs7s5nl5tp6986gqdivub